Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-day versus 7-day antibiotic therapy for mild leptospirosis
2019-004037-17Phase 4Active
- Sponsor
- CHU de Martinique
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin, doxycycline and ceftriaxone in leptospirosis (2 arms), sponsored by CHU de Martinique. Primary endpoint: Treatment failure at 7 days from the beginning of antibiotic therapy. Started Dec 2020; status: active.
02
Drugs
amoxicillindoxycyclineceftriaxone
03
Conditions
leptospirosis
Beyond the preview
Go deeper on 2019-004037-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004037-17.